Medtronic’s In.Pact AV Drug-Coated Balloon Effectively Treats Hemodialysis Access Lesions In Trial

The In.Pact AV paclitaxel-coated balloon outperformed plain angioplasty balloons in the IN.PACT AV Access trial, the first large, multi-center randomized trial comparing a drug-coated balloon to standard balloon angioplasty in the treatment of hemodialysis arteriovenous access stenoses.

Medtronic

The first large randomized trial of drug-coated balloons to treat hemodialysis arteriovenous access stenoses showed Medtronic PLC’s In.Pact AV paclitaxel-coated angioplasty balloon produces superior outcomes compared to standard angioplasty balloons.

Arteriovenous access sites, also known as AV fistulae, are surgically created to facilitate hemodialysis in patients with end-stage renal disease....

More from Clinical Trials

More from R&D